Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study

This study aimed to evaluate the mixed and homogeneous application of the inactivated SARS-CoV-2 vaccine CoronaVac (CV) and the mRNA vaccine BNT162b2 (BNT). This prospective cohort study included 235 health care workers who had received two prime shots with CoronaVac. They were divided into three co...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Hakan Demirhindi, Burak Mete, Ferdi Tanir, Ertan Kara, Filiz Kibar, Salih Cetiner, Aslihan Candevir, Sukriye Ece Akti
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2022-04-01
سلاسل:	Vaccines
الموضوعات:	COVID-19 vaccines seroconversion inactivated SARS-CoV2 vaccine BNT162 vaccine COVID-19 vaccine booster shot heterologous vaccination
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/10/5/687
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!